Effect of intravenous infusions of thiamine on the disposition kinetics of thiamine and its pyrophosphate
Rattachement africain : ch, de. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
BACKGROUND: Thiamine supplementation is necessary in patients with thiamine deficiency syndromes. Experimental evidence suggests that tissue uptake and the elimination of thiamine are dose-dependent. AIM: The aim of the present study was to investigate the effect of different i.v. infusion rates of thiamine on blood concentrations of thiamine and its active metabolite thiamine pyrophosphate (TPP) and on renal excretion of thiamine. METHODS: Twelve healthy subjects received in a two-period block randomized study 150 mg thiamine intravenously over either 1 or 24 h. RESULTS: The maximum blood concentrations (Cmax) of thiamine were significantly higher after the more rapid infusion (RI; 2300 ng/mL) than after the slower infusion (SI; 177 ng/mL). The AUC of thiamine was identical after both infusion protocols. There was a slightly (10%) increased AUC of TPP (P < 0.08) after SI, whereas C(max) values were comparable. Urinary excretion of thiamine was significantly decreased from 83.6% of the applied dose after RI to 57.6% after the SI. CONCLUSIONS: Our data suggest an increased tissue uptake of thiamine when it is given as an SI compared with a RI of the same dose. It is concluded, therefore, that an SI of thiamine may be superior to RI or bolus injections to treat severe deficiency syndromes.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Effect of intravenous infusions of thiamine on the disposition kinetics of thiamine and its pyrophosphate
- Date Crossref
- 01/02/2003
- Éditeur
- Hindawi Limited
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Où se fait cette recherche
-
University of Basel pays non établi dans la noticeUniversité ou école supérieure
-
Kantonsspital Baselland pays non établi dans la noticeÉtablissement de santé
-
Philipps University of Marburg Department of Pharmaceutics pays non établi dans la noticeUniversité ou école supérieure
-
University Clinic Division of Clinical Pharmacology and Toxicology pays non établi dans la noticeUniversité ou école supérieure
University of Basel, Kantonsspital Baselland et Department of Pharmaceutics — Philipps University of Marburg, avec 1 autre affiliation.
Une affiliation ne permet pas de déduire la nationalité d’un auteur.